cancer doctors

Prostate Cancer Prognosis

Question: What's the prognosis for prostate cancer that has spread to the liver? 68 year old man in otherwise good health, midway through chemo intended to deal with this issue, cancer has metastasized.

Answer: Probably not good if it has spread to the liver.


Prostate Cancer Prognosis News

The Epigenetic promise for prostate cancer diagnosis - Abstract

UroToday
Improvements in disease management would have a significant impact and could be facilitated by the development of biomarkers, whether for diagnostic, prognostic, or predictive purposes. The blood-based prostate biomarker PSA has been part of clinical ...
 

MedPage Today

Brachytherapy Ups Prostate Cancer Survival
MedPage Today
 

Prostate Size Predicts Gleason Score Upgrading

Oncology Nurse Advisor
(HealthDay News) ? For men with low-risk prostate cancer, prostate size is an independent predictor of Gleason score upgrading, according to a study published in the December issue of The Journal of Urology. Judson Davies, MD, of the Vanderbilt ...
 

USA TODAY

Writer Vince Flynn aims for a 'Kill Shot' against cancer
USA TODAY
 

Workouts Shape Up Genes, Prognosis in Prostate Ca

MedPage Today
This study found that regular vigorous exercise tones down tumor promoter genes and up-regulates tumor suppressor genes for men with prostate cancer. Note that working out for at least three hours a week was associated with modulation of cell cycle and ...
 

Dendreon Announces Presentation of PROVENGE Data at the ASCO 2012 ...

MarketWatch (press release)
"An Analysis to Quantify the Overall Survival (OS) Benefit of Sipuleucel-T Accounting for the Crossover in the Control Arm of the IMPACT Study," abstract #144. General Poster Session B: Prostate Cancer (D7) from 5:05 to 6:35 pm PT on Thursday, ...
 

Prognostic determinants in prostate cancer - Abstract

UroToday
Clinical outcomes in prostate cancer are heterogeneous, and given the high prevalence of the disease, there is a pressing need to identify clinically useful markers of prognosis. Many clinical, pathological, molecular, and genetic factors have been ...
 

Is Nice shirking its duty of care by blocking the Abiraterone prostate cancer ...

Telegraph.co.uk (blog)
Nice has made this decision despite acknowledging that Abiraterone has proved itself able to extend the life of men in the final stages of prostate cancer by up to four months and, at the same time, improve the man's quality of life by reducing ...
 

Outcome Magazine

Work on Oncology Centre to be resumed
Trinidad Guardian
 

Detailed results from ALSYMPCA phase III study highlight the positive impact ...

Reuters
Details of the Presentations Poster title: Abstract #9: Radium-223 chloride impact on skeletal-related events in patients with castration-resistant prostate cancer (CRPC) with bone metastases: A phase III randomized trial (ALSYMPCA).
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer